Liquid biopsy: a step forward towards precision medicine in urologic malignancies
Abstract There is a growing trend towards exploring the use of a minimally invasive “liquid biopsy” to identify biomarkers in a number of cancers, including urologic malignancies. Multiple aspects can be assessed in circulating cell-free DNA, including cell-free DNA levels, integrity, methylation an...
Main Authors: | Ashley Di Meo, Jenni Bartlett, Yufeng Cheng, Maria D. Pasic, George M. Yousef |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12943-017-0644-5 |
Similar Items
-
Editorial: Precision Medicine and Translational Research in Urological Oncology
by: Rong Na, et al.
Published: (2022-07-01) -
New Perspectives on the Role of Liquid Biopsy in Bladder Cancer: Applicability to Precision Medicine
by: Fernardo Alberca-del Arco, et al.
Published: (2024-02-01) -
Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism
by: Jennifer H. Gunter, et al.
Published: (2022-03-01) -
Transperineal Parallel Biopsy of the Prostate: A New Approach of Tissue Sampling for Precision Medicine
by: Qu M, et al.
Published: (2021-05-01) -
Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer
by: Ana Julia Aguiar de Freitas, et al.
Published: (2022-09-01)